Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

The RNA analysis market is poised for significant growth due to rising demand in precision medicine, advancements in NGS technologies, and expanding use of RNA biomarkers in diagnostics and drug ...

Riverwater Partners, an investment management company, released its “Micro Opportunities Strategy” Q4 2025 investor letter. A copy of the letter can be downloaded here. Both Q4 and the full year 2025 ...

A strong stock as of late has been Natural Gas Services (NGS). Shares have been marching higher, with the stock up 11.9% over the past month. The stock hit a new 52-week high of $32.47 in the previous ...

Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716, United States Department of Biological Sciences, University of Delaware, Newark, Delaware 19716, United States ...

Sarcomas exhibit low mutational burden, complicating precision oncology; NGS identifies potential biomarkers and tumor-agnostic targets. NGS is not routinely supported in sarcoma care; selective ...

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best therapeutic options for patients with cancer. We had an exciting discussion at ...

Kevin Y. Chen, PharmD, MS, BCOP, CPP, discusses how next-generation sequencing improves biomarker testing and treatment planning in solid tumors. Next-generation sequencing (NGS) has transformed how ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...